Krystal Biotech
KRYS
#2044
Rank
A$13.82 B
Marketcap
A$466.67
Share price
-2.19%
Change (1 day)
42.15%
Change (1 year)

Earnings for Krystal Biotech (KRYS)

Earnings in 2026 (TTM): A$0.33 Billion

According to Krystal Biotech's latest financial reports the company's current earnings are A$0.47 Billion. In 2025 the company made an earning of A$0.24 Billion, an increase over its 2024 earnings that were of A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Krystal Biotech from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.33 B35.67%
2025 A$0.24 B56.24%
2024 A$0.15 B700.38%
2023 A$19.48 M-110.98%
2022 -A$0.18 Billion72.56%
2021 -A$0.11 Billion111.4%
2020 -A$48.66 Million45.85%
2019 -A$33.36 Million85.28%
2018 -A$18.01 Million149.78%
2017 -A$7.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-168.63%๐Ÿ‡บ๐Ÿ‡ธ USA